Literature DB >> 9223629

The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins.

J Van Rampelbergh1, P Poloczek, I Françoys, C Delporte, J Winand, P Robberecht, M Waelbroeck.   

Abstract

The PACAP receptor (PACAP I receptor, selective for PACAP) and the PACAP II VIP1 receptor (recognizing PACAP and VIP with the same high affinity) were stably expressed in Chinese Hamster Ovary (CHO) cells. Cell lines expressing different receptor densities, as measured by binding saturation curves, were selected. Inositol phosphate production was stimulated dose dependently in all the cell lines by PACAP and VIP, and the order of potency of the agonists was identical to that of high affinity receptor occupancy. The stimulatory effect of a saturating peptide concentration was proportional to the total receptor density. At similar receptor densities, however, the PACAP receptor mediated stimulation was higher than the VIP receptor-mediated stimulation. Pretreatment of the cells with pertussis toxin for 8 h had no effect on receptor densities, did not alter the PACAP stimulated inositol phosphate synthesis by the cells expressing the PACAP I receptor but markedly inhibited the response of the cells expressing the PACAP II VIP1 receptor. Thus, the present results indicate that the two G(s)-coupled PACAP I and PACAP II VIP1 receptors may stimulate IP production. The maximal stimulation depended on the number of receptor expressed; the PACAP I and PACAP II VIP1 receptors probably activated the phospholipase C through G proteins of the G(q), and of the G(i)/G(o) families, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223629     DOI: 10.1016/s0167-4889(97)00028-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/PACAP (PAC1) receptors.

Authors:  E M Lutz; C J MacKenzie; M Johnson; K West; J A Morrow; A J Harmar; R Mitchell
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry.

Authors:  Rebecca J Hermann; Travis Van der Steen; Emilie E Vomhof-Dekrey; Sejaa Al-Badrani; Steve B Wanjara; Jarrett J Failing; Jodie S Haring; Glenn P Dorsam
Journal:  J Immunol Methods       Date:  2011-11-04       Impact factor: 2.303

3.  Regulation of spinal dynorphin 1-17 release by endogenous pituitary adenylyl cyclase-activating polypeptide in the male rat: relevance of excitation via disinhibition.

Authors:  Nai-Jiang Liu; Stephen A Schnell; Stefan Schulz; Martin W Wessendorf; Alan R Gintzler
Journal:  J Pharmacol Exp Ther       Date:  2010-10-25       Impact factor: 4.030

4.  Vasoactive intestinal peptide enhances TNF-α-induced IL-6 and IL-8 synthesis in human proximal renal tubular epithelial cells by NF-κB-dependent mechanism.

Authors:  Ling Huang; Yiting Tang; Jiao Qin; Yu Peng; Qiongjing Yuan; Fangfang Zhang; Lijian Tao
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

5.  VPAC1 and VPAC2 receptor activation on GABA release from hippocampal nerve terminals involve several different signalling pathways.

Authors:  Diana Cunha-Reis; Joaquim Alexandre Ribeiro; Rodrigo F M de Almeida; Ana M Sebastião
Journal:  Br J Pharmacol       Date:  2017-11-29       Impact factor: 8.739

Review 6.  Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine.

Authors:  Tahlia Sundrum; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

7.  Stimulant action of pituitary adenylate cyclase-activating peptide on normal and drug-compromised peristalsis in the guinea-pig intestine.

Authors:  A Heinemann; P Holzer
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

8.  Vasoactive intestinal polypeptide requires parallel changes in adenylate cyclase and phospholipase C to entrain circadian rhythms to a predictable phase.

Authors:  Sungwon An; Robert P Irwin; Charles N Allen; Connie Tsai; Erik D Herzog
Journal:  J Neurophysiol       Date:  2011-03-09       Impact factor: 2.714

9.  Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behavior.

Authors:  Ichiko Nishijima; Takanori Yamagata; Corinne M Spencer; Edwin J Weeber; Olga Alekseyenko; J David Sweatt; Mariko Y Momoi; Masayuki Ito; Dawna L Armstrong; David L Nelson; Richard Paylor; Allan Bradley
Journal:  Hum Mol Genet       Date:  2006-09-28       Impact factor: 6.150

10.  Insights into synaptic function from mouse models of human cognitive disorders.

Authors:  Jessica L Banko; Justin Trotter; Edwin J Weeber
Journal:  Future Neurol       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.